1. Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation
   Jin Wook Lee et al, 2023, Experimental & Molecular Medicine CrossRef
2. Idebenone is a cytoprotective insulin sensitizer whose mechanism is Shc inhibition
   Alexey Tomilov et al, 2018, Pharmacological Research CrossRef
3. Efficacy and Safety of a Fixed-Dose Combination of Candesartan and Rosuvastatin on Blood Pressure and Cholesterol in Patients With Hypertension and Hypercholesterolemia: A Multicenter, Randomized, Double-Blind, Parallel Phase III Clinical Study
   Kyoung Im Cho et al, 2019, Clinical Therapeutics CrossRef
4. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways
   Nesma M.E. Abo El- Nasr et al, 2020, European Journal of Pharmacology CrossRef
5. Candesartan Does Not Activate PPARγ and Its Target Genes in Early Gestation Trophoblasts
   Lena Neuper et al, 2022, International Journal of Molecular Sciences CrossRef